Search - tctmd.com

Displaying 1 - 9 of 9

Sort: Relevancy | Date

Presentation TCT 2024

TCT 1012: Pre-Emptive PCI in Vulnerable Coronary Plaques Reduces Biomechanical and Anatomic High-Risk Features: The PROSPECT ABSORB Trial

Presenter: Diaa Hakim

October 29, 2024

Presentation TCT 2024

TCT 1017: First-in-Human Intracoronary Structural-Molecular Imaging for Multi-Targeted Characterization of High-Risk Plaques in Patients With Coronary Artery Disease

Presenter: Dong Oh Kang

October 29, 2024

Presentation TCT 2024

Con

Presenter: Gary Mintz

October 28, 2024

Presentation TCT 2024

Pro

Presenter: Duk-Woo Park

October 28, 2024

Presentation TCT 2024

TCT 1010: Enhanced Clinical Benefit of Preventive PCI of Vulnerable Coronary Plaques in Patients With Concomitant Non-Target Vessel PCI: A Prespecified Subgroup Analysis of the PREVENT Trial

Presenter: Soo Yeon An

October 28, 2024

Presentation TCT 2024

Lipid Burden and Efficacy of Preventive PCI in Vulnerable Atherosclerotic Coronary Plaques: Post-hoc Analysis of PREVENT Trial

Presenter: Jung-Min Ahn

October 27, 2024

News Conference News SCCT 2024

AI Assessment of Plaque, Hemodynamics May ID Lesion-Specific ACS Risk

Todd Neale

July 25, 2024

News Conference News ACC 2024

PREVENT Supports Early PCI for Vulnerable Plaque, With Reductions in MACE

L.A. McKeown

April 08, 2024

Presentation ACC 2024

PREVENT: Preventive PCI versus Medical Therapy Alone for Treatment of Vulnerable Atherosclerotic Coronary Plaques

Presenter: Seung-Jung Park

April 07, 2024

Advertisement

TCT 1012: Pre-Emptive PCI in Vulnerable Coronary Plaques Reduces Biomechanical and Anatomic High-Risk Features: The PROSPECT ABSORB Trial

TCT 1017: First-in-Human Intracoronary Structural-Molecular Imaging for Multi-Targeted Characterization of High-Risk Plaques in Patients With Coronary Artery Disease

Con

Pro

TCT 1010: Enhanced Clinical Benefit of Preventive PCI of Vulnerable Coronary Plaques in Patients With Concomitant Non-Target Vessel PCI: A Prespecified Subgroup Analysis of the PREVENT Trial

Lipid Burden and Efficacy of Preventive PCI in Vulnerable Atherosclerotic Coronary Plaques: Post-hoc Analysis of PREVENT Trial

AI Assessment of Plaque, Hemodynamics May ID Lesion-Specific ACS Risk

PREVENT Supports Early PCI for Vulnerable Plaque, With Reductions in MACE

PREVENT: Preventive PCI versus Medical Therapy Alone for Treatment of Vulnerable Atherosclerotic Coronary Plaques

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content